AmandaRushingMD

MD/MPH Candidate | Class of 2021

Dr. Rushing is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1425 Madison Ave
Fl 4
New York, NY 10029
Phone+1 212-241-2087

Fax+1 212-987-9310

I am a MD/MPH student at LSUHSC in New Orleans, LA. I am interested in both clinical and molecular science with a focus on vascular surgery, epigenetics, and biotechnology.

Icahn School of Medicine at Mount SinaiResidency, Vascular Surgery - Integrated, 2021 - 2026
LSUHSC School of Public HealthMasters of Public Health, Behavioral and Community Health Science , 2017 - 2021
Louisiana State University School of Medicine in New OrleansClass of 2021
Baylor UniversityB.S., Chemistry, Magna Cum Laude, 2011 - 2014

John P. Ische Medical School Library Publication of the Month LSUHSC New Orleans, 2019
Introduction to Academic Vascular Surgery, 1st place oral presentation, Medical Student Category Society for Vascular Surgery, 2019
Diversity Scholarship, Vascular Annual Meeting, Boston, MA Society for Vascular Surgery, 2018
Jim Finks Endowed Fund Research Scholarship The Obesity Society, 2018
National Institute of Health Research Internship Vanderbilt University, Nashville, TN, 2018
Phi Beta Kappa Baylor University, 2015
Join now to see all

PubMed

1 citations
Aortoiliac endarterectomy as a viable alternative for revascularization in a woman with isolated aortoiliac disease and an anomalous right pelvic kidney.
Amanda M. Rushing, Tapash K. Palit, Malachi Sheahan
Journal of Vascular Surgery Cases and Innovative Techniques. 2021-01-28
25 citations
Effects of a novel hydrogen sulfide prodrug in a porcine model of acute limb ischemia
Amanda M. Rushing, Erminia Donnarumma, David J. Polhemus, Kevin Au, Samuel E. Victoria
Journal of Vascular Surgery. 2019-06-01
48 citations
Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
Erminia Donnarumma, Murtuza J Ali, Amanda M. Rushing, Amy Scarborough, Jessica M. Bradley
Journal of the American Heart Association. 2016-07-01

Journal Articles

Salivary Epigenetic Biomarkers as Predictors of Emerging Childhood Obesity
Rushing AM, Sommer EC, Zhao S, Poe EK, Barkin S, BMC Medical Genetics, 2/14/2020
Zofenopril protects against myocardial ischemia-reperfusion injury by increasing nitric oxide and hydrogen sulfide bioavailability
Donnarumma E., Ali M. J., Rushing A. M., J Am Heart Assoc, 6/2016

Abstracts/Posters

The Novel H2S Pro-Drug, SG-1002, Preserves Coronary Artery Vascular Reactivity in the Setting of Critical Limb Ischemia in Swine
Rushing A.M, Scarborough A.L., Boisvert S.F., Circulation, AHA Scientific Sessions, New Orleans, LA, November 2016., 11/2016
Cardioprotective Effects of the Novel Mitochondrial-Derived Peptide, Humanin, in a Porcine Model of Myocardial Ischemia-Reperfusion Injury.
Organ C.L., Murtuza A.J., Scarborough A.L, Rushing A.M, Circulation, AHA Scientific Sessions, New Orleans, LA, 11/2016
A Novel Hydrogen Sulfide Prodrug, SG-1002, Augments Angiogenesis in a Swine Model of Critical Limb Ischemia
Rushing A.M, Scarborough A.L., Boisvert S.F., Circulation, AHA Scientific Sessions, New Orleans, LA, November 2016., 11/2016
Hypercholesterolemic LDLr Knockout Swine as a Clinically Relevant Model of Hypertension. International Society for Heart Research
Rushing A.M., Scarborough A.L, Jenkins J.S., International Society for Heart Research, New Orleans, LA,, 5/2016
A Novel Fibroblast Activation Inhibitor, NM922, Attenuates Maladaptive Fibrotic Remodeling to Preserve Cardiac Function Following the Onset of Heart Failure.
Bradley J.M., Ziblich C.M., Islam K.N., Rushing A.M, Circulation, AHA Scientific Sessions, Orlando, FL, November 2015., 11/2015
Join now to see all